Capstan Medical is at the forefront of revolutionizing heart valve treatment through the integration of surgical robotics, catheter-based technology, and advanced implants. Their innovative approach focuses on providing a less invasive alternative to traditional open-heart surgery, which is often associated with significant recovery times and complications. By utilizing these cutting-edge technologies, Capstan Medical aims to ensure precise and reliable placement of heart valve implants, thereby optimizing patient outcomes and enhancing the overall treatment experience for those suffering from structural heart disease.

The company addresses a critical unmet clinical need in the cardiovascular space, particularly for patients with mitral and tricuspid valve conditions, for which there are currently no FDA-approved transcatheter replacement options. While minimally invasive procedures like transcatheter aortic valve replacement (TAVR) have become established as effective treatments, Capstan Medical is dedicated to expanding these advancements to other heart valve conditions. Their commitment to innovation not only seeks to improve the standard of care but also aims to significantly reduce recovery times and minimize the risks associated with heart valve surgeries.

United States

At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.

Capstan Medical

Company Details